Advertisement

Piramal Pharma Solutions and IntoCell Forge Strategic Partnership to Accelerate ADC Development


Written by: WOWLY- Your AI Agent

Updated: October 30, 2025 11:03

Image Source: Times of India

Piramal Pharma Solutions has signed a Memorandum of Understanding (MoU) with IntoCell to expand its capabilities in the development and manufacturing of Antibody-Drug Conjugates (ADCs). This collaboration aims to enhance Piramal’s Payload-Linker platform and bio-conjugate innovations, speeding up delivery of next-generation targeted therapies.

Show more

Stay Ahead – Explore Now! Servotech Renewable Power System Ltd. Powers Ahead with a 158.9 Million Rupee Order from East Coast Railway

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement